Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: Relationship to clinical and immunological parameters

Clinical and Experimental Allergy

Volumn 35, Issue 4, 2005, Pages 448-455

  Guzik, Tomasz J ^a,c   Bzowska, M ^a   Kasprowicz, A ^b   Czerniawska Mysik, G ^a   Wojcik K ^c   Szmyd, D ^a   Adamek Guzik, T ^a   Pryjma, Juliusz ^a,c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Ctr of Microbiol Res/Autovaccines   (Poland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

AD; Antihistamine; Atopic dermatitis; Immunoglobulin E; S. Aureus; Steroid

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; FOOD ALLERGEN; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; MOMETASONE FUROATE; POLLEN ANTIGEN; STEROID;

ADULT; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CLINICAL ARTICLE; DERMATITIS; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOCYTE; HUMAN; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY BURST; SKIN; SKIN TEST; STAPHYLOCOCCUS AUREUS;

ADMINISTRATION, TOPICAL; ADULT; ANTI-ALLERGIC AGENTS; CD4-CD8 RATIO; CETIRIZINE; DERMATITIS, ATOPIC; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; IMMUNOGLOBULIN E; MALE; NOSE; PHARYNX; PREGNADIENEDIOLS; SKIN; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 17744371699     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02210.x     Document Type: Article

References (36)

1. Akdis CA, Akdis M. Immunological differences between intrinsic and extrinsic types of atopic dermatitis. Clin Exp Allergy 2003; 33:1618-21.
2. Jung T. New treatments for atopic dermatitis. Clin Exp Allergy 2002; 32:347-54.
3. Breuer K, Kapp A, Werfel T. Bacterial infections and atopic dermatitis. Allergy 2001; 56:1034-41.
4. Jeong CW, Ahn KS, Rho NK et al. Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. extrinsic atopic dermatitis patients using semiquantitative RT-PCR. Clin Exp Allergy 2003; 33:1717-24.
5. Von Linstow ML, Porsbjerg C, Ulrik CS, Nepper-Christensen S, Backer V. Prevalence and predictors of atopy among young Danish adults. Clin Exp Allergy 2002; 32:520-5.
6. Lubbe J. Secondary infections in patients with atopic dermatitis. Am J Clin Dermatol 2003; 4:641-54.
7. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974; 90:525-30.
8. Ring J, Abeck D, Neuber K. Atopic eczema: role of microorganisms on the skin surface. Allergy 1992; 47:265-9.
9. Morishita Y, Tada J, Sato A et al. Possible influences of Staphylococcus aureus on atopic dermatitis - the colonizing features and the effects of staphylococcal enterotoxins. Clin Exp Allergy 1999; 29:1110-7.
10. Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 1992; 27:29-34.
11. Strange P, Skov L, Lisby S, Nielsen PL, Baadsgaard O. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 1996; 132: 27-33.
12. Bunikowski R, Mielke M, Skarabis H et al. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol 1999; 103:119-24.
13. Nomura I, Tanaka K, Tomita H et al. Evaluation of the Staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis. J Allergy Clin Immunol 1999; 104: 441-446.
14. Sharp MJ, Rowe J, Kusel M, Sly PD, Holt PG. Specific patterns of responsiveness to microbial antigens Staphylococcal enterotoxin B and purified protein derivative by cord blood mononuclear cells are predictive of risk for development of atopic dermatitis. Clin Exp Allergy 2003; 33:435-41.
15. Cho SH, Strickland I, Tomkinson A, Fehringer AP, Gelfand EW, Leung DY. Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model. J Invest Dermatol 2001; 116:658-63.
16. Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347:1151-60.
17. Ellis CN, Stevens SR, Blok BK, Taylor RS, Cooper KD. Interferon-gamma therapy reduces blood leukocyte levels in patients with atopic dermatitis: correlation with clinical improvement. Clin Immunol 1999; 92:49-55.
18. Nuttall TJ, Knight PA, McAleese SM, Lamb JR, Hill PB. Expression of Th1, Th2 and immunosuppressive cytokine gene transcripts in canine atopic dermatitis. Clin Exp Allergy 2002; 32:789-95.
19. Yudate T, Yamada H, Tezuka T. Role of Staphylococcal enterotoxins in pathogenesis of atopic dermatitis: growth and expression of T cell receptor V beta of peripheral blood mononuclear cells stimulated by enterotoxins A and B. J Dermatol Sci 1996; 13:63-70.
20. Al-Mohana F, Parhar R, Kawaasi A et al. Inhibition of neutrophil functions by human immunoglobulin E. J. Allergy Clin Immunol 1993; 92:575-66.
21. Lever R, Hadley K, Downey D, Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988; 119:189-98.
22. Stalder JF, Fleury M, Sourisse M, Rostin M, Pheline F, Litoux P. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol 1994; 131:536-40.
23. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92:44-47.
24. Adamek-Guzik T, Guzik TJ, Czerniawska-Mysik G et al. Urinary leukotriene levels are increased during exacerbation of atopic eczema/dermatitis syndrome. Relation to clinical status. Allergy 2002; 57:732-6.
25. Goodyear HM, Watson PJ, Egan SA, Price EH, Kenny PA, Harper JI. Skin microflora of atopic eczema in first time hospital attenders. Clin Exp Dermatol 1993; 18:300-4.
26. Goh CL, Wong JS, Giam YC. Skin colonization of Staphylococcus aureus in atopic dermatitis patients seen at the National Skin Centre, Singapore. Int J Dermatol 1997; 36:653-7.
27. Pournaras CC, Lubbe J, Saurat JH. Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (Fk506). J Invest Dermatol 2001; 116:480-1.
28. Jutel M, Watanabe T, Klunker S et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001; 413:420-5.
29. Platts-Mills TA. The role of immunoglobulin E in allergy and asthma. Am J Respir Crit Care Med 2001; 164:S1-5.
30. Yamaguchi M, Lantz C, Oetten H et al. IgE enhances mouse mast cell FceRI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997; 185:663-672.
31. Patella V, Florio G, Oriente A et al. in Mast Cells and Basophils. San Diego: Academic Press, 2000.
32. Matsui K, Nishikawa A. Lipoteichoic acid from Staphylococcus aureus enhances allergen-specific immunoglobulin E production in mice. Clin Exp Allergy 2003; 33: 842-8.
33. Hill H, Quie PG. Raised serum IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet 1974; 9:183-7.
34. Yoshino T, Asada H, Sano S et al. Impaired responses of peripheral blood mononuclear cells to staphylococcal superantigen in patients with severe atopic dermatitis: a role of T cell apoptosis. J Invest Dermatol 2000; 114:281-8.
35. Tur E. Physiology of the skin- differences between women and men. Clin Dermatol 1997; 15:5-16.
36. Best GK, Abney TO, Kling JM, Kirkland JJ, Scott DF. Hormonal influence on experimental infections by a toxic shock strain of Staphylococcus aureus. Infect Immun 1986; 52:331-3.